| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8K | — | — |
| R&D Expense | $4.7M | -0.4% | +17.0% |
| SG&A Expense | $3.5M | +13.8% | +19.5% |
| Operating Income | -$8.2M | -5.2% | -18.1% |
| Net Income | -$8.0M | -6.6% | -22.9% |
| EPS (Basic) | -$0.21 | -5.0% | -10.5% |
| EPS (Diluted) | -$0.21 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $16.2M | -24.3% | -42.0% |
| Current Assets | $21.6M | -26.3% | -40.1% |
| Total Assets | $25.0M | -22.5% | -38.0% |
| Current Liabilities | $5.1M | -26.6% | -7.7% |
| Total Liabilities | $6.4M | -23.4% | -10.9% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.1M | — | — |
| Capital Expenditures | $662K | — | — |
| Investing Cash Flow | $5.6M | — | — |
| Financing Cash Flow | $9.6M | — | — |
| Free Cash Flow | -$19.7M | — | — |
| -10.5% |
| $18.6M |
| -22.2% |
| -43.8% |